The Pharmaceutical Studies Reader

Title Page
Copyright Page
Contents
Acknowledgements
Chapter 1 Introduction
Why Study Pharmaceuticals?
A Prehistory of Pharmaceutical Studies
Key Themes in Pharmaceutical Studies
Guide to this Volume
Notes
Part I Pharmaceutical Lives
Chapter 2 The Pharmaceuticalisation of Society? A Framework for Analysis
Introduction
Definition, Delineation and Dynamics: What is Pharmaceuticalisation?
Trends and Transformations
Discussion
References
Chapter 3 Pharmaceutical Witnessing: Drugs for Life in an Era of Direct-to-Consumer Advertising
Remaking the Body at Risk
Awareness Through Education
Personalizing the Risk
Motivation to Informing Self-diagnosis
Convincing the Doctor, the Critical Moment
Branded Compliance
Conclusion
Note
References
Part II New Drugs, Diseases, and Identities
Chapter 4 Releasing the Flood Waters: Diuril and the Reshaping of Hypertension
Introduction
Diuril in the Life of the Pharmaceutical Firm
Attachment: Diuril Meets Hypertension
Clinical Research as a Marketing Arena
Public Relations and Popular Media
“Ethical Marketing”: The Detail Man and the Diuril Man
Reception: Diuril and Hypertension in Practice
Expanding the Ranks of the Treatable
Detaching “Diuril” from Hypertension
Notes
Chapter 5 Dep®ession and Consum♀tion: Psychopharmaceuticals, Branding, and New Identity Practices
Introduction
Branded Identity and “Symbolic Mistakes”: The New Social Lives of Pharmaceuticals
Markets, Molecules and Meanings
Sarafeminism?
Premenstrual Dysphoric Disorder in the Making
Symbolic Side Effects
Marketing (and) Medical Turf: Symbolic Fallout
Conclusions
Notes
References
Chapter 6 BiDil: Medicating the Intersection of Race and Heart Failure
Considering Heart Failure as a Disease Category
BiDil’s Contingent History: V-HeIT to A-HeIT
Too High a Price?
Pharmakon
The Material-semiotic
Conclusion
Notes
Works Cited
Chapter 7 Manufacturing Desire: The Commodification of Female Sexual Dysfunction
New Diagnoses for New Drugs: Creating a Market
The Commodification of Continuing Medical Education
The Celebrity of the ‘Sex Expert’: Media and the Commodification of Female Sexual Dysfunction
Robust Pipelines
Notes
References
Part III Drugs and the Circulation of Medical Knowledge
Chapter 8 Following the Script: How Drug Reps Make Friends and Influence Doctors
Better than You Know Yourself
Script Tracking
The Value of Samples
Funding Friendship
Conclusion
References
Chapter 9 Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster
From Schizophrenia to Complicated Moods: The Evolution of Zyprexa
Marketing Channels and Synergistic Power: Conclusion
Notes
References
Chapter 10 Pushing Knowledge in the Drug Industry: Ghost-Managed Science
Introduction
A Sample Manuscript
Publication Planning 101/201: An Insider View of the Field
Marketing
Medical Journals
Authorship and its Limits
Creating Knowledge Through Mediation
Changing Trajectories?
Discussion
Notes
References
Chapter 11 Transcultural Medicine: A Multi-Sited Ethnography on the Scientific-Industrial Networking of Korean Medicine
A Brief Modern History of Korean Medicine and its Transformation
KM Doctors’ Global Experiences: Biographical Accounts
Hybrid and Modernized Practice: The Production of Hybrid KM Treatments in the KM Clinic
Laboratory Practice and the Scientization of Herbal Therapies
Network of Networks: Industrialization Process of Herbal Medicine in the Purimed Company
Transcultural Medicine and Emergence of New Medical Assemblage in Global Power Relations
Conclusion
Notes
References
Part IV Political and Moral Economies of Pharmaceutical Research
Chapter 12 Uncommon Trajectories: Steroid Hormones, Mexican Peasants, and the Search for a Wild Yam
Introduction
Hormones in the Laboratory
In Search of a Wild Yam
The Birth of Syntex
George Rosenkranz and the Study of Chemistry in Mexico
Human Faces Beyond the Laboratories: Mexicans Search for Barbasco
Carl Djerassi: Syntex, Cortisone, and an Amazing Mexican Yam
Conclusion
Notes
References
Chapter 13 “Ready-to-Recruit” or “Ready-to-Consent” Populations?: Informed Consent and the Limits of Subject Autonomy
Recruitment and Informed Consent
Analysis of Advertisements
Participation and Informed Consent
Conclusion
Notes
References
Chapter 14 Clinical Trials Offshored: On Private Sector Science and Public Health
Clinical Trial Environments
Pharmaceutical Capital: Contract Research in Brief
Constructing Global Subjects
Keeping the Clinical Trial Market in Poland
‘Pharmaceuticals are the New Gold’
Notes
References
Chapter 15 The Experimental Machinery of Global Clinical Trials: Case Studies from India
The Indian Clinical Trials Landscape
A Critique of the Global Biomedical Economy: Expropriation, Exploitation, and the Structural Violence of Biocapital
Notes
Part V Intellectual Property in Local and Global Markets
Chapter 16 Intellectual Property and Public Health: Copying of HIV/AIDS Drugs by Brazilian Public and Private Pharmaceutical Laboratories
Introduction
Public Health Policy and Local Production of Generic Drugs
The Unpatentable Status of Drugs in Brazil from 1945 to 1996: A Licit Copying Regime
Copying and Technological Learning
Copying and Pharmaceutical Innovations
Conflict Between the Brazilian Health Ministry and International Laboratories: Negotiations on Prices and Compulsory Licences
Conclusions
Notes
Chapter 17 Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis’ Anti-Cancer Drug Glivec
Novartis versus the Government of India
Pharmaceutical Citizens versus Novartis
Pharmaceutical Citizens Pro Novartis
Give to the Poor to Take from the Rich
Note
References
Chapter 18 Generic Medicines and the Question of the Similar
A New Market?
The Similar and the “Similar”
Generics and the Social Studies of Science and Technology
Notes
References
Index
EULA